Narrative intervention to disseminate ACT for depression in primary care

在初级保健中传播针对抑郁症的 ACT 的叙事干预

基本信息

  • 批准号:
    9220647
  • 负责人:
  • 金额:
    $ 17.67万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-03-01 至 2019-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The public health impact of existing treatments for depression is limited by our ability to disseminate those treatments. There is a particular need to find innovative ways to disseminate key principles of empirically supported psychotherapy in primary care settings. Over half of U.S. residents who receive mental health care receive it in primary care, and primary care can reach many who might not access psychiatric care due to perceived stigma or other barriers. Narrative communication is an alternative way to disseminate key principles of psychotherapy that catalyze behavior change. Narrative communication refers to "storytelling" -real people telling stories about their struggles and successful ways of coping. Narrative interventions can result in behavior change for other problems, such as hypertension. An advantage of narrative communication is that it can be easily distributed (by video), can be very engaging, and may reach people who do not have access to other technologies or who experience barriers to traditional psychotherapy. We propose that key principles of a type of cognitive-behavioral therapy (Acceptance and Commitment Therapy, or ACT) can be disseminated through a video storytelling intervention. ACT is an empirically-supported therapy for depression and related problems. Key principles for catalyzing behavior change and alleviating depression include: 1) striving for consistency between personal values and daily actions; 2) being more willing to experience negative thoughts/ feelings in the service of personal values; 3) viewing negative thoughts/feelings as transient; and 4) being more fully present (or mindful) in everyday life. There are two primary aims of this treatment development project. First, together with a video production firm, we will produce a storytelling video intervention (sTVi), with real primary care patients discussing their own (ACT-consistent) successful coping strategies. Using an iterative process, we will create 4 30-minute "episodes" intended to be viewed over the course of a month; we will also create an accompanying workbook. Second, we will conduct a) a small open trial (n = 10) of sTVi and b) pilot randomized controlled trial (n = 40) with depressed primary care patients receiving antidepressant medication treatment as usual (TAU) + sTVi vs. TAU + attention control videos. Assessments will occur at baseline and 4 and 12 weeks. We will examine feasibility and acceptability of sTVi (by examining uptake and completion of sTVi, whether the videos are considered engaging, and whether viewers understand key ACT principles and see them as relevant to their lives) and of the RCT research design. We will examine treatment differences (within relevant confidence intervals) on outcomes (e.g., depression). We will examine change in hypothesized mechanisms, i.e., ACT-consistent coping strategies. The next step in this line of research is to test, in a large- scale randomized controlled trial, the efficacy of sTVi as an adjunct to antidepressant medication in depressed primary care patients, and to examine ACT-consistent coping strategies as mechanisms of action.
描述(由申请人提供):现有治疗对抑郁症的公共卫生影响受我们传播这些治疗的能力的限制。特别需要 寻找创新的方法来传播初级保健环境中经验支持的心理治疗的关键原则。接受精神卫生保健的美国居民中,有一半以上的居民在初级保健中获得了医疗保健,并且由于感知到的污名或其他障碍而无法获得精神病医生的许多人。叙事交流是传播心理疗法关键原理的另一种方法,从而催化行为改变。叙事交流是指“讲故事” - 真实的人讲述他们的斗争和成功的应对方式的故事。叙事干预措施可能会导致其他问题(例如高血压)的行为改变。叙事交流的优势是(通过视频)可以很容易地分发,很可能很吸引人,并且可能会吸引那些无法获得其他技术或遇到传统心理治疗障碍的人。我们建议可以通过视频讲故事的干预来传播一种认知行为疗法(接受和承诺疗法或行为)的关键原则。 ACT是一种经验支持抑郁症和相关问题的经验疗法。催化行为变化和减轻抑郁症的关键原则包括:1)努力在个人价值观和日常行动之间保持一致性; 2)更愿意在为个人价值观服务时体验负面的想法/感受; 3)将负面思想/感觉视为短暂的; 4)在日常生活中更充分地存在(或正念)。该治疗开发项目有两个主要目标。首先,与一家视频制作公司一起,我们将制作讲故事的视频干预(STVI),而真正的初级保健患者讨论了自己的(一致)成功应对策略。使用迭代过程,我们将创建4个30分钟的“情节”,旨在在一个月的过程中观看;我们还将创建一个随附的工作簿。其次,我们将进行a)STVI和b)试验随机对照试验(n = 40)的小型开放试验(n = 10),初级保健抑郁症患者像往常一样接受抗抑郁药治疗(TAU) + STVI + STVI + TAU +注意控制视频。评估将在基线和4和12周进行。我们将检查STVI的可行性和可接受性(通过检查STVI的吸收和完成,视频是否被视为引人入胜,以及观众是否了解关键ACT原则并将其视为与他们的生活有关)和RCT研究设计。我们将在结果(例如抑郁症)上检查治疗差异(相关置信区间)。我们将研究假设机制的变化,即行动一致的应对策略。这项研究系列的下一步是在大规模的随机对照试验中测试STVI作为抑郁症的初级保健患者抗抑郁药的辅助性的功效,并检查行动一致的应对策略作为作用机制。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Development of a Storytelling Video Self-Help Intervention Based on Acceptance and Commitment Therapy for Major Depression: Open Trial Results.
基于接受和承诺疗法的重度抑郁症讲故事视频自助干预的开发:公开试验结果。
  • DOI:
    10.1177/0145445517738932
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    2.3
  • 作者:
    Gaudiano,BrandonA;Davis,CarterH;Miller,IvanW;Uebelacker,LisaA
  • 通讯作者:
    Uebelacker,LisaA
Pilot randomized controlled trial of a video self-help intervention for depression based on acceptance and commitment therapy: Feasibility and acceptability.
基于接受和承诺疗法的抑郁症视频自助干预的试点随机对照试验:可行性和可接受性。
  • DOI:
    10.1002/cpp.2436
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    3.6
  • 作者:
    Gaudiano,BrandonA;Davis,CarterH;Miller,IvanW;Uebelacker,Lisa
  • 通讯作者:
    Uebelacker,Lisa
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BRANDON A GAUDIANO其他文献

BRANDON A GAUDIANO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BRANDON A GAUDIANO', 18)}}的其他基金

Effectiveness of a multi-component mHealth intervention to improve post-hospital transitions of care for patients with SMI
多组成部分移动医疗干预对改善 SMI 患者出院后护理过渡的有效性
  • 批准号:
    10502609
  • 财政年份:
    2022
  • 资助金额:
    $ 17.67万
  • 项目类别:
Development of an adjunctive video-based suicide prevention intervention immediately following psychiatric hospitalization
在精神病院住院后立即开发基于视频的辅助自杀预防干预措施
  • 批准号:
    10296677
  • 财政年份:
    2020
  • 资助金额:
    $ 17.67万
  • 项目类别:
Development of an adjunctive video-based suicide prevention intervention immediately following psychiatric hospitalization
在精神病院住院后立即开发基于视频的辅助自杀预防干预措施
  • 批准号:
    9894972
  • 财政年份:
    2020
  • 资助金额:
    $ 17.67万
  • 项目类别:
RCT to Improve Post-Hospital Treatment Adherence for Comorbid Substance Use and Bipolar Disorders
随机对照试验可提高共病药物使用和双相情感障碍的出院后治疗依从性
  • 批准号:
    10015339
  • 财政年份:
    2019
  • 资助金额:
    $ 17.67万
  • 项目类别:
RCT to Improve Post-Hospital Treatment Adherence for Comorbid Substance Use and Bipolar Disorders
随机对照试验可提高共病药物使用和双相情感障碍的出院后治疗依从性
  • 批准号:
    10456650
  • 财政年份:
    2019
  • 资助金额:
    $ 17.67万
  • 项目类别:
RCT to Improve Post-Hospital Treatment Adherence for Comorbid Substance Use and Bipolar Disorders
随机对照试验可提高共病药物使用和双相情感障碍的出院后治疗依从性
  • 批准号:
    10218024
  • 财政年份:
    2019
  • 资助金额:
    $ 17.67万
  • 项目类别:
Mobile After-Care Support Intervention for Patients with Schizophrenia following Hospitalization
精神分裂症患者住院后的移动善后支持干预
  • 批准号:
    9924664
  • 财政年份:
    2018
  • 资助金额:
    $ 17.67万
  • 项目类别:
Narrative intervention to disseminate ACT for depression in primary care
在初级保健中传播针对抑郁症的 ACT 的叙事干预
  • 批准号:
    9002100
  • 财政年份:
    2015
  • 资助金额:
    $ 17.67万
  • 项目类别:
Effectiveness of Psychosocial Treatment for Inpatients with Psychosis
心理社会治疗对住院精神病患者的有效性
  • 批准号:
    8696880
  • 财政年份:
    2013
  • 资助金额:
    $ 17.67万
  • 项目类别:
Technology-Assisted Assessment of Post-Hospital Adherence in Schizophrenia
精神分裂症出院后依从性的技术辅助评估
  • 批准号:
    8703805
  • 财政年份:
    2013
  • 资助金额:
    $ 17.67万
  • 项目类别:

相似国自然基金

碳网间植入载金MOFs管阵列的三维分子印迹传感器及其对地平类降压药的手性识别研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    54 万元
  • 项目类别:
    面上项目
碳网间植入载金MOFs管阵列的三维分子印迹传感器及其对地平类降压药的手性识别研究
  • 批准号:
    22274096
  • 批准年份:
    2022
  • 资助金额:
    54.00 万元
  • 项目类别:
    面上项目
降压药对细胞内钙空间分布及膜钙电流与血压关系的研究
  • 批准号:
    39370792
  • 批准年份:
    1993
  • 资助金额:
    6.0 万元
  • 项目类别:
    面上项目
降压药转换酶抑制剂对肾脏保护作用及机理的探讨
  • 批准号:
    39170848
  • 批准年份:
    1991
  • 资助金额:
    3.0 万元
  • 项目类别:
    面上项目
血小板心房利钠因子受休及其临床研究
  • 批准号:
    38970362
  • 批准年份:
    1989
  • 资助金额:
    2.0 万元
  • 项目类别:
    面上项目

相似海外基金

RAS-Driven Central Inflammation and Cognitive Decline with Aging.
RAS 驱动的中枢炎症和认知能力随着衰老而下降。
  • 批准号:
    10453781
  • 财政年份:
    2021
  • 资助金额:
    $ 17.67万
  • 项目类别:
RAS-Driven Central Inflammation and Cognitive Decline with Aging.
RAS 驱动的中枢炎症和认知能力随着衰老而下降。
  • 批准号:
    10301248
  • 财政年份:
    2021
  • 资助金额:
    $ 17.67万
  • 项目类别:
Adult Changes in Thought (ACT) Research Program Core C: Life Course Core
成人思想转变 (ACT) 研究计划核心 C:生命历程核心
  • 批准号:
    10404973
  • 财政年份:
    2021
  • 资助金额:
    $ 17.67万
  • 项目类别:
Adult Changes in Thought (ACT) Research Program Core C: Life Course Core
成人思想转变 (ACT) 研究计划核心 C:生命历程核心
  • 批准号:
    10672349
  • 财政年份:
    2021
  • 资助金额:
    $ 17.67万
  • 项目类别:
Mechanisms of Cognitive Decline Across Socioeconomic and Clinical Contexts
社会经济和临床背景下认知衰退的机制
  • 批准号:
    10120416
  • 财政年份:
    2017
  • 资助金额:
    $ 17.67万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了